Schedule

From Microcolonies to Lysis Patterns:Modelling Spatial and Stochastic Effects in Phage-Bacteria Interactions

12:35 - 12:40 PM Investigating the role of gene transfer agents in Rhodobacter capsulatus survival and DNA repair during stationary phase (Tori Cable) 12:40 - 12:45 PM Same day, low cost long read sequencing of phage genomes directly from single plaques (Brenna Fox) 12:45 - 12:50 PM Development of a Storage Formulation Increasing the Stability of Bacteriophages (Nicolas Denault) 12:50 - 12:55 PM Bacteriophage-based biocontrol of Pseudomonas syringae complex- a sustainable approach for managing bacterial blight in highbush blueberry (Israt Ara Hossain) 12:55 - 1:00 PM Bridging Technology & Biology: Rapid Phage Testing for Urinary Tract Infections (Lina Siddiq) 1:00 - 1:10 PM QA panel

Molecular evolution of a phage endolysin reveals genetic and structural insights into host specificity

1:50 - 2:10 PM From Chaos to Convergence: Modelling Gut Virome Diversity, Dynamics, and Function Across 12 Infant Cohorts (Michael Shamash) 2:10 - 2:30 PM Empathi: Embedding-based Phage Protein Annotation Tool by Hierarchical Assignment (Alexandre Boulay) 2:30 - 2:50 PM Isolation and Characterization of 80 Novel Bacteriophages (Adam Rudner & Undergraduate students) 2:50 - 3:10 PM Addressing Antimicrobial Resistance (AMR) Threats with Phage Therapy (PT): An International Clinician Survey and Personalized-Phage against E.coli with IV Antibiotic to Knockout Stable Biofilms (P-PEAKS) in Urinary Tract Infections (UTIs) Clinical Trial Design (Dinuri Punchihewa)

Dr. Danielle Peters (Research Officer, National Research Council of Canada’s Human Health Therapeutics Research Centre) Dr. Michael Parcey (Senior biologist and head of the Phage Science, Therapeutics, and Research (PhageSTAR) unit, Public Health Agency of Canada)